Since we launched our first IVD test kit in 1966 our products have consistently been recognized by the market for their excellence.
We have carried out a number of successful acquisitions of best-in-class IVD companies over the years (e.g. Centocor Diagnostics in 1998, CanAg Diagnostics in 2006 and Innogenetics in 2010).
This has further reinforced the know-how in our group and bolstered our capacity to innovate, develop, produce and deliver products of only the highest quality.
Products by diseases and disorders:
News & EventsView all news & upcoming events
Fujirebio Europe launches the Lumipulse® G Aldosterone and Renin assays for fully automated quantitative determination of aldosterone and active renin
iAMP COVID-19 Detection kit, a molecular SARS-CoV-2 detection assay distributed by Fujirebio Europe, is now CE marked
Fujirebio Europe launches the automated Lumipulse® G SCC assay for the quantitative measurement of squamous cell carcinoma antigen
Fujirebio Europe launches iAMP COVID-19, a new molecular detection assay that eliminates the need for RNA extraction
Healthcare for You.
With our deep involvement in human health, we aim to be a group that contributes to the development of healthcare through trust and innovation.
What we hold dear is the starting point for the creation of a prosperous future.
That is, the health of each and every person.
Because we have been watching over people's health for many decades, we are able to change the future of medical care and create new possibilities in healthcare.
We will continue the challenge to deliver optimal healthcare to each individual.
We will move forward, unceasingly.
Healthcare for You.
For your health, for your future happiness.
A global partner of choice
Today, we sell our products in more than 100 countries worldwide.
We have offices in the United States, Latin America, Europe and Asia, and are supported by an international distribution network and leading OEMs.
Our proven commitment to manufacturing quality has earned us a strong reputation with our direct customers, and global partners at leading diagnostic companies.
Our own Rebecca Millecamps, Marketing Manager at Fujirebio, was interviewed for the podcast series 'Molecules, microbes and multiomics' about the...
Jun 22, 2020
There are many reference centers across Europe that have included KL-6 as one of the biomarkers within the COVID-19 protocol to strengthen the battery...
Apr 30, 2020
Automation is an important step in the direction of more standardization as it limits the number of manual handling steps and therefore minimizes...
Mar 16, 2020